Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-006464
Filing Date
2019-07-29
Accepted
2019-07-29 16:06:14
Documents
51
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20190630x10q.htm 10-Q 1812032
2 EX-31.1 rytm-20190630ex31169e749.htm EX-31.1 16330
3 EX-31.2 rytm-20190630ex31248ee69.htm EX-31.2 15672
4 EX-32.1 rytm-20190630ex321f5e241.htm EX-32.1 8482
5 EX-32.2 rytm-20190630ex3225c2540.htm EX-32.2 8465
  Complete submission text file 0001558370-19-006464.txt   4263040

Data Files

Seq Description Document Type Size
6 EX-101.INS rytm-20190630.xml EX-101.INS 636935
7 EX-101.SCH rytm-20190630.xsd EX-101.SCH 25540
8 EX-101.CAL rytm-20190630_cal.xml EX-101.CAL 36583
9 EX-101.DEF rytm-20190630_def.xml EX-101.DEF 62785
10 EX-101.LAB rytm-20190630_lab.xml EX-101.LAB 233267
11 EX-101.PRE rytm-20190630_pre.xml EX-101.PRE 172765
Mailing Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116
Business Address 222 BERKELEY STREET 12TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 19981228
SIC: 2834 Pharmaceutical Preparations